# DECADRON — FDA application NDA011977

Informational only - not investment advice.

Application NDA011977 · type NDA · FDA status: approved · original approval 1959-09-02

Listed sponsor: MERCK · [MRK company profile](/company/MRK/) · exact_unique

Sponsor as listed in Drugs@FDA at retrieval (2026-08-07); FDA sponsor listings can lag ownership transfers.

## FDA application facts

| Product | FDA-listed trade name | Active ingredient | Dosage form | Route | Strength | Marketing status | TE code | RLD |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 001 | DECADRON | DEXAMETHASONE SODIUM PHOSPHATE | OINTMENT | OPHTHALMIC | EQ 0.05% PHOSPHATE | Discontinued | not listed | No |

## Orange Book patent and exclusivity listings

No Orange Book patent or exclusivity listings joined to this application.

Patent and exclusivity dates are regulatory listings from the FDA Orange Book; no relationship to revenue or future sales is stated or implied.

## Compound cross-links

- DEXAMETHASONE SODIUM PHOSPHATE · UNII not resolved · no lmmol compound match

Ingredient–compound links use FDA openFDA/GSRS identifiers and an exact lmmol InChIKey join. Ingredient names cannot create a link.

## Related pages

- [Sponsor company](/company/MRK/)
- [FDA-approved application index](/drug/)
- [Large-cap biopharma](/compare/pharma/)

Sources: https://www.fda.gov/drugs/drug-approvals-and-databases/drugsfda-data-files · https://www.fda.gov/drugs/drug-approvals-and-databases/orange-book-data-files · https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA011977. FDA data retrieved 2026-08-07.

Regulatory listing data as published by FDA; not medical or investment advice.